These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 15148260)
1. Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist. Luk T; Jin W; Zvonok A; Lu D; Lin XZ; Chavkin C; Makriyannis A; Mackie K Br J Pharmacol; 2004 Jun; 142(3):495-500. PubMed ID: 15148260 [TBL] [Abstract][Full Text] [Related]
2. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes. Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365 [TBL] [Abstract][Full Text] [Related]
3. Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. Wu DF; Yang LQ; Goschke A; Stumm R; Brandenburg LO; Liang YJ; Höllt V; Koch T J Neurochem; 2008 Feb; 104(4):1132-43. PubMed ID: 17986216 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes. Oz M; Zhang L; Ravindran A; Morales M; Lupica CR J Pharmacol Exp Ther; 2004 Sep; 310(3):1152-60. PubMed ID: 15102930 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of cannabinoid receptor ligands: current status. Singh J; Budhiraja S Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344 [TBL] [Abstract][Full Text] [Related]
9. Activation of G-proteins in brain by endogenous and exogenous cannabinoids. Childers SR AAPS J; 2006 Mar; 8(1):E112-7. PubMed ID: 16584117 [TBL] [Abstract][Full Text] [Related]
10. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Hanus L; Abu-Lafi S; Fride E; Breuer A; Vogel Z; Shalev DE; Kustanovich I; Mechoulam R Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3662-5. PubMed ID: 11259648 [TBL] [Abstract][Full Text] [Related]
11. Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018. Finlay DB; Nguyen T; Gamage TF; Chen S; Barrus DG; Patel PR; Thomas BF; Wiley JL; Zhang Y; Glass M Pharmacol Res Perspect; 2022 Feb; 10(1):e00901. PubMed ID: 35041297 [TBL] [Abstract][Full Text] [Related]
12. Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells. Nieri P; Romiti N; Adinolfi B; Chicca A; Massarelli I; Chieli E Br J Pharmacol; 2006 Jul; 148(5):682-7. PubMed ID: 16715117 [TBL] [Abstract][Full Text] [Related]
13. Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids. Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S Acta Biol Hung; 2007; 58 Suppl():113-29. PubMed ID: 18297798 [TBL] [Abstract][Full Text] [Related]
14. G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Lewohl JM; Wilson WR; Mayfield RD; Brozowski SJ; Morrisett RA; Harris RA Nat Neurosci; 1999 Dec; 2(12):1084-90. PubMed ID: 10570485 [TBL] [Abstract][Full Text] [Related]
15. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. Jin W; Brown S; Roche JP; Hsieh C; Celver JP; Kovoor A; Chavkin C; Mackie K J Neurosci; 1999 May; 19(10):3773-80. PubMed ID: 10234009 [TBL] [Abstract][Full Text] [Related]
16. Effects of interferon-alpha on cloned opioid receptors expressed in Xenopus oocytes. Kobayashi T; Washiyama K; Ikeda K Life Sci; 2004 Dec; 76(4):407-15. PubMed ID: 15530503 [TBL] [Abstract][Full Text] [Related]
17. Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures. Bojnik E; Turunç E; Armağan G; Kanıt L; Benyhe S; Yalçın A; Borsodi A Epilepsy Res; 2012 Mar; 99(1-2):64-8. PubMed ID: 22079489 [TBL] [Abstract][Full Text] [Related]
18. (4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs. Mahmoud MM; Olszewska T; Liu H; Shore DM; Hurst DP; Reggio PH; Lu D; Kendall DA Mol Pharmacol; 2015 Feb; 87(2):197-206. PubMed ID: 25411367 [TBL] [Abstract][Full Text] [Related]
19. Site of action of the general anesthetic propofol in muscarinic M1 receptor-mediated signal transduction. Murasaki O; Kaibara M; Nagase Y; Mitarai S; Doi Y; Sumikawa K; Taniyama K J Pharmacol Exp Ther; 2003 Dec; 307(3):995-1000. PubMed ID: 14534362 [TBL] [Abstract][Full Text] [Related]
20. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways. Sterin-Borda L; Del Zar CF; Borda E Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]